Search

for
Search:

Products matching "benign specificity"

Tracking 1 products like 157 Finast (Finasteride 5mg) from by companies like Inhouse Pharmacy. View product »

Research

5 / 1000+ results

research AI03 Steps towards safely deploying the world’s first autonomous artificial intelligence as a medical device for skin cancer into a National Health Service teledermatology pathway

June 2025 in “British Journal of Dermatology”

An AI device for skin cancer was successfully integrated into the NHS, improving diagnosis accuracy and service capacity.

research Rhodamin B Stain for Keratin: Evaluation of its Specificity and its Application in Dermal Pathology

9 citations , August 1980 in “Journal of Cutaneous Pathology”

Rhodamin B stain is inconsistent for keratin in skin samples.

research Novel inhibitors of 5α-reductase

20 citations , February 2002 in “Expert Opinion on Therapeutic Patents”

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

research Therapeutic Androgen Receptor Ligands

16 citations , January 2003 in “Nuclear Receptor Signaling”

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

research Measurement of tamsulosin in human serum by liquid chromatography–tandem mass spectrometry

9 citations , April 2013 in “Journal of Chromatography B”

A reliable method was created to measure tamsulosin in human blood.

View more "benign specificity" in research →

Community Join

2 / 1000+ results

community FCE 28260: A Forgotten 5α-Reductase Inhibitor

in Research 330 upvotes 1 year ago

FCE 28260 (PNU 156765), an under-explored 5α-reductase inhibitor, showcases promising results in research by Giudici et al., outperforming well-known treatments like Finasteride in reducing the conversion of testosterone to DHT. Its superior efficacy, demonstrated through lower IC50 values in both natural and human recombinant enzyme studies, suggests it could offer more effective management of DHT-related conditions. Additionally, its lower molecular weight hints at better potential for topical application, potentially offering advantages in treating conditions such as androgenic alopecia. Despite its potential, it has not advanced in development, possibly due to financial limitations, leaving its therapeutic prospects and side effect profile largely unexplored.

community From the research study: "Dihydrotestosterone and the concept of 5a-reductase inhibition in human benign prostatic hyperplasia" - G. Bartsch, R.S. Rittmaster, H. Klocker (2002) in the "World Journal of Urology".

in Research/Science 23 upvotes 4 years ago

Dutasteride is a stronger 5AR inhibitor than finasteride and can significantly lower DHT levels. Reduced doses of dutasteride may lower side effects.

View more "benign specificity" in community →

Learn

— no results

Try a deeper search in learn →

Experts

— no results

Try a deeper search in experts →

Clinics

— no results

Try a deeper search in clinics →